Open | 0.81 |
Previous Close | 0.8302 |
Day Range | 0.76 - 0.82 |
52-Week Range | 0.74 - 2.43 |
All-Time High | 147.68 |
Avg. Volume (50-day) | 847,740.56 |
EPS (TTM) | -1.3359 |
Next Earnings Date | 2025-05-13 (AMC) |
Last Earnings Date | 2025-03-06 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | Yes |
P/E Ratio | -0.6200 |
PEG Ratio | - |
Price to Book | 0.37 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | - |
Revenue per Share (TTM) | - |
Shares Outstanding | 82.686 M |
Share Float (%) | 65.36 M |
% Held by Institutions | 50.68 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 0.83 (-9.04%) |
+/- SMA(50) | 0.88 (-14.20%) |
+/- SMA(200) | 1.18 (-36.02%) |
5-Day Perf. | -17.42% |
1-Month Perf. | -16% |
3-Month Perf. | -21.52% |
6-Month Perf. | -47.57% |
YTD Perf. | -21.52% |
1-Year Perf. | -67.87% |
RSI(14) | 40 |
ATR(14) | 0.07 |
ADX(14) | 17.82 |
Beta (5Y) | 1.27 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
ACET has triggered the following predefined scans:
P&F Double Bottom Breakdown |
Parabolic SAR Sell Signals |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.